3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine
C22H26FN5O — CID 92621480
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine
3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine (PubChem CID 92621480) has the molecular formula C22H26FN5O and a molecular weight of 395.48 g/mol. Its IUPAC name is 3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine.
Molecular Properties
| Compound Name | 3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine |
|---|---|
| PubChem CID | 92621480 |
| Molecular Formula | C22H26FN5O |
| Molecular Weight | 395.48 g/mol |
| Exact Mass | 395.21 |
| IUPAC Name | 3-[[(2R)-2-[5-[2-(2-fluorophenoxy)ethyl]-1H-pyrazol-3-yl]pyrrolidin-1-yl]methyl]-N-methylpyridin-2-amine |
| SMILES | CNc1ncccc1CN1CCC[C@@H]1c1cc(CCOc2ccccc2F)[nH]n1 |
| InChI | InChI=1S/C22H26FN5O/c1-24-22-16(6-4-11-25-22)15-28-12-5-8-20(28)19-14-17(26-27-19)10-13-29-21-9-3-2-7-18(21)23/h2-4,6-7,9,11,14,20H,5,8,10,12-13,15H2,1H3,(H,24,25)(H,26,27)/t20-/m1/s1 |
| InChIKey | WNRAHFANEZEJQO-HXUWFJFHSA-N |
| XLogP | 3.94 |
| TPSA | 66.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 395.48 |
| LogP ≤ 5 | 3.94 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 92621480 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.